MADISON, Wis., Sept. 10, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Cellular Dynamics, a leading global developer and manufacturer of human induced pluripotent stem cells (iPSCs) today announces the global ...
Human-induced pluripotent stem cells (iPSCs) can be utilized to study complex health conditions in in vitro platforms relevant to humans. It is possible to reprogram human iPSC lines from patient ...
AMSBIO (Oxford, UK) announces an innovative range of induced pluripotent stem cell (iPSC) kits for researchers requiring a rapid, reproducible, and scalable means of generating specific neural cell ...
Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in ...
Human induced pluripotent stem cell (iPSC)-derived motor neurons (in green) co-cultured with iPSC-derived astrocytes (in red). [VIB] Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s ...
In Alzheimer’s and other diseases with complex genetics, differentiating a single induced pluripotent stem cell (iPSC) line from a single endpoint cell may improperly represent the underlying ...
The MarketWatch News Department was not involved in the creation of this content. BEACHWOOD, Ohio, July 23, 2025 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company ...
The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...
11don MSN
New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death
University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...
When brain cells die in diseases like ALS (amyotrophic lateral sclerosis) and frontotemporal dementia, they often activate a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results